EHEileen M. Handberg

Eileen M. Handberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eileen M. Handberg has a total of 813 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Brachial Pulse Pressure and Outcomes: A Report From the WISE Study

    by Juan Vilaro, Eileen M. Handberg, George Sopko, Galen Cook-Wiens, Carl J. Pepine, C. Noel Bairey Merz


  • Open Access

    Electrocardiographic Predictors of Major Adverse Cardiovascular Events in Women With Suspected Ischemia and no Obstructive Coronary Artery Disease: Results of the Women's Ischemia Syndrome Evaluation

    by Jennifer R. Dungan, Yasmeen K. Taha, Qinglin Pei, Michael T. Weaver, Michael J. Tavormina, Steven E. Reis, Eileen M. Handberg, C. Noel Bairey Merz, Carl J. Pepine

    Introduction: An estimated four million individuals have suspected Ischemia and No Obstructive Coronary Arteries (INOCA), often due to coronary microvascular dysfunction, a subtype of ischemic heart disease that disproportionately affects women. Previously hypothesized as a benign condition, patients with INOCA demonstrate an elevated risk profile for major adverse cardiovascular events (MACE), yet biomarkers to inform this risk have not been identified. Methods: To examine ECG indices as predictors of MACE among women with INOCA, we conducted a secondary analysis of the Women's Ischemia Syndrome Evaluation (WISE) original cohort in 481 women with suspected INOCA and complete data. Cox multivariable regression analysis was conducted in baseline ECG indices (intervals, rate, rhythm, and abnormalities) and their association with time‐to‐incident MACE (angina hospitalization, myocardial infarction, stroke, heart failure, revascularization with stent or angioplasty, or all‐cause death). Cox proportional hazards modeling was performed as time from study enrollment to event censored on days to last contact, using stepwise backward selection and bootstrapping for model determination. Results: Overall, 165 (34.3%) experienced at least one MACE, including 26 (5.41%) all cause deaths, over an average follow‐up time of 5.25 years. Significant predictors in the final model were resting heart rate (RHR), race, CHF, depression, and use of nitrates within 24 h of ECG measurement. Higher RHR was associated with increased hazards of incident composite MACE (adjusted hazard ratio 1.018, p = 0.0348). Conclusion: Identifying unique biomarkers for MACE among women with INOCA is a clinical and research priority to inform screening and prevention strategies.


  • Assessment and Management of Cardiovascular Risk in Women

    by Jo-Ann Eastwood, Margo B. Minissian, Eileen M. Handberg

  • Open Access

    Dietary Composition, Angiographic Coronary Disease, and Cardiovascular Outcomes in the WISE Study (Women’s Ischemia Syndrome Evaluation)

    by Brandon H. Schwartz, So Yung Choi, Anne Mathews, Monica Aggarwal, Eileen M. Handberg, Carl J. Pepine, William Rogers, Steven Reis, Galen Cook-Wiens, C. Noel Bairey Merz, et al.

    Background: Studies relating diet to angiographic coronary artery disease (CAD) and subsequent major adverse cardiac events (MACE) in women are limited. Information on diet was collected in the Women’s Ischemia Syndrome Evaluation (WISE), a prospective cohort study of symptomatic women referred for coronary angiography to evaluate suspected ischemic heart disease. Methods: A consecutive subgroup (n = 201 of 936) of enrolled women completed the modified Block food frequency questionnaire (FFQ). Data on outcomes were collected and adjudicated after 8-year follow-up. A set of logistic regression models were fitted for non-obstructive versus obstructive coronary stenosis (2. An increased proportion of calories consumed from protein was associated with higher levels of baseline obstructive coronary stenosis. Those individuals who ate a higher amount of protein, carotene, and servings of vegetables and meat, however, were each associated with lower subsequent adverse outcomes, respectively. Conclusions: Among women undergoing coronary angiography for suspected CAD, a higher percentage of protein intake was associated with higher baseline stenosis severity; however, the amount of protein intake, vegetable, meat, and carotene intake, was conversely associated with subsequent lower adverse cardiovascular outcome risk.

  • Open Access

    Symptom Presentation among Women with Suspected Ischemia and No Obstructive Coronary Artery Disease (INOCA)

    by Yasmeen K. Taha, Jennifer R. Dungan, Michael T. Weaver, Ke Xu, Eileen M. Handberg, Carl J. Pepine, C. Noel Bairey Merz

    Identifying ischemic heart disease (IHD) in women based on symptoms is challenging. Women are more likely to endorse non-cardiac symptoms. More than 50% of women with suspected ischemia have no obstructive coronary disease (and thus, INOCA) and impaired outcomes during follow-up. We aimed to identify symptoms having predictive capacity for INOCA in women with clinical evidence of coronary ischemia. We included 916 women from the original WISE cohort (NCT 00000554) who had coronary angiography performed for suspected ischemia and completed a 65-item WISE symptom questionnaire. Sixty-two percent (n = 567) had suspected INOCA. Logistic regression models using a best subsets approach were examined to identify the best predictive model for INOCA based on Score χ2 and AICc. A 10-variable, best-fit model accurately predicted INOCA (AUC 0.72, 95% CI 0.68, 0.75). The model indicated that age ≤ 55 years, left side chest pain, chest discomfort, neck pain, and palpitations had independent, positive relationship (OR > 1) to INOCA (p < 0.001 to 0.008). An inverse relationship (OR < 1) was observed for impending doom, and pain in the jaw, left or bilateral arm, and right hand, interpreted as INOCA associated with the absence of these symptoms (p ≤ 0.001 to 0.023). Our best-fit model accurately predicted INOCA based on age and symptom presentation ~72% of the time. While the heterogeneity of symptom presentation limits the utility of this unvalidated 10-variable model, it has promise for consideration of symptom inclusion in future INOCA prediction risk modeling for women with evidence of symptomatic ischemia.


  • Long-Term Adverse Outcomes in Black Women With Ischemia and No Obstructive Coronary Artery Disease: A Study of the WISE (Women’s Ischemia Syndrome Evaluation) Cohort

    by Judy M. Luu, Pankaj Malhotra, Galen Cook-Wiens, Carl J. Pepine, Eileen M. Handberg, Steven E. Reis, Nathaniel Reichek, Vera Bittner, Janet Wei, Sheryl F. Kelsey, et al.


  • Open Access

    Influence of Butyrate on Impaired Gene Expression in Colon from Patients with High Blood Pressure

    by Jing Li, Elaine M. Richards, Eileen M. Handberg, Carl J. Pepine, Eyad Alakrad, Chris E. Forsmark, Mohan K. Raizada

    Hypertension (HTN) is associated with gut dysbiosis and the depletion of butyrate-producing bacteria in animal models and people. Furthermore, fecal material transfer from donor hypertensive patients increases blood pressure in normotensive recipient animals and ameliorates HTN-associated pathophysiology. These observations have implications in the impaired interactions between the gut and gut microbiota in HTN. Although this concept is supported in animal models, little is known about human HTN. Therefore, our objective for this study was to compare gene expression with transcriptomics and its potential to influence microbiota in subjects with normal and high blood pressure (HBP). Colon samples from reference subjects with normal blood pressure (REF) and HBP were used for RNA-seq to analyze their transcriptomes. We observed the significant downregulation of gene sets governing immune responses (e.g., SGK1 and OASL), gut epithelial function (e.g., KRT20 and SLC9A3R1), gut microbiota (e.g., PPARG and CIDEC) and genes associated with cardiovascular and gut diseases (e.g., PLAUR and NLN) in HBP subjects; the expression of genes within these pathways correlated with blood pressure. Potential drug targets in the gut epithelium were identified using the Drug Gene International Database for possible use in HTN. They include peroxisome proliferator-activated receptor gamma (PPRG), active serum/glucocorticoid regulated kinase 1 (SGK1) and 3 beta-hydroxysteroid isomerase type II inhibitor (HSD3B). Finally, butyrate, a microbiota-derived short-chain fatty acid, restored the disrupted expression of certain functional genes in colonic organoids from HBP subjects. Patients with HBP exhibit a unique transcriptome that could underlie impaired gut–microbiota interactions. Targeting these interactions could provide a promising new therapeutic intervention for hypertension management.


  • Hypertension

    by Matthew Petersen, Steven Brady, Eileen M. Handberg, Monica Aggarwal

    Hypertension is present in roughly half of the US population and raises the risk and prevalence of cardiovascular disease, kidney disease, heart attack, and stroke. Many patients have difficulty controlling their blood pressure despite many available pharmaceuticals. This chapter explores the pathophysiology and definition of hypertension, as well as many lifestyle-based modifications that patients can make to improve blood pressure and reduce the risk of adverse cardiovascular events. The pathophysiology of hypertension is multifactorial and affected by neurohormonal signals, levels of inflammation, multiorgan feedback regulation, and is directly affected by physical activity and nutrient consumption. Routine physical activity as well as several diets, such as the well-known DASH and Mediterranean diets, which recommend low levels of fat and salt, and high levels of whole foods, fruits, and vegetables, have been shown to effectively reduce blood pressure. Many nutritional minerals and vitamins also play a role in blood pressure regulation. These vitamins and minerals can act through vasodilatory, anti-inflammatory or electrolyte regulatory mechanisms to help augment blood pressure lowering. In summary, there are many lifestyle modifications, ranging from research-proven diets, to exercise, to dietary supplementation, that can help lower blood pressure and reduce risk of poor health outcomes.

  • Potential of Minocycline for Treatment of Resistant Hypertension

    by Carl J. Pepine, Alexander Thiel, Seungbum Kim, Eileen M. Handberg, Elaine M. Richards, Osama Dasa, Mohammed Mohammed, Steven M. Smith, Rhonda M. Cooper-DeHoff, Mohan K. Raizada